X4 Pharmaceuticals Inc’s filing revealed that its Executive Chairman Craig Adam R acquired Company’s shares for reported $0.25 million on Oct 23 ’25. In the deal valued at $2.90 per share,86,206 shares were bought. As a result of this transaction, Craig Adam R now holds 376,087 shares worth roughly $1.44 million.
Then, Baldry Mark bought 1,032 shares, generating $2,561 in total proceeds. Upon buying the shares at $2.48, the Chief Commercial Officer now owns 25,337 shares.
Before that, Ragan Paula sold 76,473 shares. X4 Pharmaceuticals Inc shares valued at $34,719 were divested by the President and CEO at a price of $0.45 per share. As a result of the transaction, Ragan Paula now holds 1,087,386 shares, worth roughly $4.18 million.
A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Neutral”. Cantor Fitzgerald started covering the stock on December 22, 2022. It rated XFOR as “an Overweight”.
Price Performance Review of XFOR
On Monday, X4 Pharmaceuticals Inc [NASDAQ:XFOR] saw its stock fall -3.52% to $3.84. Over the last five days, the stock has gained 21.90%. X4 Pharmaceuticals Inc shares have fallen nearly -66.54% since the year began. Nevertheless, the stocks have fallen -82.55% over the past one year. While a 52-week high of $26.83 was reached on 01/02/25, a 52-week low of $1.35 was recorded on 08/11/25.
Levels Of Support And Resistance For XFOR Stock
The 24-hour chart illustrates a support level at 3.71, which if violated will result in even more drops to 3.58. On the upside, there is a resistance level at 3.96. A further resistance level may holdings at 4.08.
How much short interest is there in X4 Pharmaceuticals Inc?
A steep rise in short interest was recorded in X4 Pharmaceuticals Inc stocks on 2025-11-14, growing by 0.16 million shares to a total of 1.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 1.79 million shares. There was a rise of 8.08%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 12, 2022 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $3 price target.
